Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03576131 · OUTCOME

Area Under Plasma Concentration-time Curve From Time Zero to the Time of Last Nonzero Concentration (AUC[0-Clast]) of Hx-DR5-01 and Hx-DR5-05

GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors · Source last updated 2023-08-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
GEOMETRIC_MEAN
Unit
µg*h/mL
Interval / dispersion
Geometric Coefficient of Variation
Time frame
Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3

What was measured

The AUC(0-Clast) of Hx-DR5-01 and Hx-DR5-05 are reported.

Analysis population: PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.

Groups in this outcome

Biweekly Regimen (GEN1029 0.1 mg/kg)

Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.

Biweekly Regimen (GEN1029 0.2 mg/kg)

Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.

Biweekly Regimen (GEN1029 0.3 mg/kg)

Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.

Biweekly Regimen (GEN1029 1.0 mg/kg)

Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.

Biweekly Regimen (GEN1029 2.0 mg/kg)

Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.

Biweekly Regimen (GEN1029 3.0 mg/kg)

Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)9
Biweekly Regimen (GEN1029 0.2 mg/kg)7
Biweekly Regimen (GEN1029 0.3 mg/kg)4
Biweekly Regimen (GEN1029 1.0 mg/kg)11
Biweekly Regimen (GEN1029 2.0 mg/kg)7
Biweekly Regimen (GEN1029 3.0 mg/kg)6

Reported measurements

AUC(0-Clast) Hx-DR5-01 Cycle 1 Day 1

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)9
Biweekly Regimen (GEN1029 0.2 mg/kg)6
Biweekly Regimen (GEN1029 0.3 mg/kg)4
Biweekly Regimen (GEN1029 1.0 mg/kg)11
Biweekly Regimen (GEN1029 2.0 mg/kg)7
Biweekly Regimen (GEN1029 3.0 mg/kg)6
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
Biweekly Regimen (GEN1029 0.1 mg/kg)24.3673.2Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.2 mg/kg)72.2570.6Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.3 mg/kg)60.7835.8Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 1.0 mg/kg)460.3743.5Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 2.0 mg/kg)1173.715.6Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 3.0 mg/kg)1058.988.6Not reportedNot reportedNot reported
AUC(0-Clast) Hx-DR5-01 Cycle 2 Day 1

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)9
Biweekly Regimen (GEN1029 0.2 mg/kg)4
Biweekly Regimen (GEN1029 0.3 mg/kg)4
Biweekly Regimen (GEN1029 1.0 mg/kg)8
Biweekly Regimen (GEN1029 2.0 mg/kg)5
Biweekly Regimen (GEN1029 3.0 mg/kg)2
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
Biweekly Regimen (GEN1029 0.1 mg/kg)17.34141.3Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.2 mg/kg)70.3366.4Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.3 mg/kg)21.8536.0Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 1.0 mg/kg)308.7466.8Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 2.0 mg/kg)582.5784.8Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 3.0 mg/kg)2291.418.1Not reportedNot reportedNot reported
AUC(0-Clast) Hx-DR5-01 Cycle 3 Day 1

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)7
Biweekly Regimen (GEN1029 0.2 mg/kg)4
Biweekly Regimen (GEN1029 0.3 mg/kg)3
Biweekly Regimen (GEN1029 1.0 mg/kg)6
Biweekly Regimen (GEN1029 2.0 mg/kg)3
Biweekly Regimen (GEN1029 3.0 mg/kg)1
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
Biweekly Regimen (GEN1029 0.1 mg/kg)22.3485.9Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.2 mg/kg)35.31151.4Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.3 mg/kg)6.85995.0Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 1.0 mg/kg)385.5423.7Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 2.0 mg/kg)986.3830.1Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 3.0 mg/kg)2444.7NANot reportedNot reportedGeometric coefficient of variation was not derived as only one participant was evaluated for this arm.
AUC(0-Clast) Hx-DR5-05 Cycle 1 Day 1

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)9
Biweekly Regimen (GEN1029 0.2 mg/kg)6
Biweekly Regimen (GEN1029 0.3 mg/kg)4
Biweekly Regimen (GEN1029 1.0 mg/kg)11
Biweekly Regimen (GEN1029 2.0 mg/kg)7
Biweekly Regimen (GEN1029 3.0 mg/kg)6
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
Biweekly Regimen (GEN1029 0.1 mg/kg)25.41120.7Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.2 mg/kg)53.7677.0Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.3 mg/kg)53.8050.8Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 1.0 mg/kg)432.1824.5Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 2.0 mg/kg)956.0218.8Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 3.0 mg/kg)964.4891.1Not reportedNot reportedNot reported
AUC(0-Clast) Hx-DR5-05 Cycle 2 Day 1

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)9
Biweekly Regimen (GEN1029 0.2 mg/kg)4
Biweekly Regimen (GEN1029 0.3 mg/kg)4
Biweekly Regimen (GEN1029 1.0 mg/kg)8
Biweekly Regimen (GEN1029 2.0 mg/kg)4
Biweekly Regimen (GEN1029 3.0 mg/kg)2
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
Biweekly Regimen (GEN1029 0.1 mg/kg)24.85119.4Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.2 mg/kg)60.7576.0Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.3 mg/kg)29.17165.1Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 1.0 mg/kg)258.6760.5Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 2.0 mg/kg)395.5062.3Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 3.0 mg/kg)2176.011.7Not reportedNot reportedNot reported
AUC(0-Clast) Hx-DR5-05 Cycle 3 Day 1

Analysis denominator · Participants

GroupSource count
Biweekly Regimen (GEN1029 0.1 mg/kg)7
Biweekly Regimen (GEN1029 0.2 mg/kg)4
Biweekly Regimen (GEN1029 0.3 mg/kg)2
Biweekly Regimen (GEN1029 1.0 mg/kg)6
Biweekly Regimen (GEN1029 2.0 mg/kg)3
Biweekly Regimen (GEN1029 3.0 mg/kg)1
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation
GroupValueSpreadLowerUpperComment
Biweekly Regimen (GEN1029 0.1 mg/kg)20.12168.7Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.2 mg/kg)16.95539.4Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 0.3 mg/kg)43.56405.4Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 1.0 mg/kg)158.9876.4Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 2.0 mg/kg)52.1622162.5Not reportedNot reportedNot reported
Biweekly Regimen (GEN1029 3.0 mg/kg)2248.1NANot reportedNot reportedGeometric coefficient of variation was not derived as only one participant was evaluated for this arm.
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        73.2
        value
        24.36
      2. group Id
        OG001
        spread
        70.6
        value
        72.25
      3. group Id
        OG002
        spread
        35.8
        value
        60.78
      4. group Id
        OG003
        spread
        43.5
        value
        460.37
      5. group Id
        OG004
        spread
        15.6
        value
        1173.7
      6. group Id
        OG005
        spread
        88.6
        value
        1058.9
    denoms
    1. counts
      1. group Id
        OG000
        value
        9
      2. group Id
        OG001
        value
        6
      3. group Id
        OG002
        value
        4
      4. group Id
        OG003
        value
        11
      5. group Id
        OG004
        value
        7
      6. group Id
        OG005
        value
        6
      units
      Participants
    title
    AUC(0-Clast) Hx-DR5-01 Cycle 1 Day 1
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        141.3
        value
        17.34
      2. group Id
        OG001
        spread
        66.4
        value
        70.33
      3. group Id
        OG002
        spread
        36.0
        value
        21.85
      4. group Id
        OG003
        spread
        66.8
        value
        308.74
      5. group Id
        OG004
        spread
        84.8
        value
        582.57
      6. group Id
        OG005
        spread
        18.1
        value
        2291.4
    denoms
    1. counts
      1. group Id
        OG000
        value
        9
      2. group Id
        OG001
        value
        4
      3. group Id
        OG002
        value
        4
      4. group Id
        OG003
        value
        8
      5. group Id
        OG004
        value
        5
      6. group Id
        OG005
        value
        2
      units
      Participants
    title
    AUC(0-Clast) Hx-DR5-01 Cycle 2 Day 1
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        85.9
        value
        22.34
      2. group Id
        OG001
        spread
        151.4
        value
        35.31
      3. group Id
        OG002
        spread
        995.0
        value
        6.85
      4. group Id
        OG003
        spread
        23.7
        value
        385.54
      5. group Id
        OG004
        spread
        30.1
        value
        986.38
      6. comment
        Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.
        group Id
        OG005
        spread
        NA
        value
        2444.7
    denoms
    1. counts
      1. group Id
        OG000
        value
        7
      2. group Id
        OG001
        value
        4
      3. group Id
        OG002
        value
        3
      4. group Id
        OG003
        value
        6
      5. group Id
        OG004
        value
        3
      6. group Id
        OG005
        value
        1
      units
      Participants
    title
    AUC(0-Clast) Hx-DR5-01 Cycle 3 Day 1
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        120.7
        value
        25.41
      2. group Id
        OG001
        spread
        77.0
        value
        53.76
      3. group Id
        OG002
        spread
        50.8
        value
        53.80
      4. group Id
        OG003
        spread
        24.5
        value
        432.18
      5. group Id
        OG004
        spread
        18.8
        value
        956.02
      6. group Id
        OG005
        spread
        91.1
        value
        964.48
    denoms
    1. counts
      1. group Id
        OG000
        value
        9
      2. group Id
        OG001
        value
        6
      3. group Id
        OG002
        value
        4
      4. group Id
        OG003
        value
        11
      5. group Id
        OG004
        value
        7
      6. group Id
        OG005
        value
        6
      units
      Participants
    title
    AUC(0-Clast) Hx-DR5-05 Cycle 1 Day 1
  5. categories
    1. measurements
      1. group Id
        OG000
        spread
        119.4
        value
        24.85
      2. group Id
        OG001
        spread
        76.0
        value
        60.75
      3. group Id
        OG002
        spread
        165.1
        value
        29.17
      4. group Id
        OG003
        spread
        60.5
        value
        258.67
      5. group Id
        OG004
        spread
        62.3
        value
        395.50
      6. group Id
        OG005
        spread
        11.7
        value
        2176.0
    denoms
    1. counts
      1. group Id
        OG000
        value
        9
      2. group Id
        OG001
        value
        4
      3. group Id
        OG002
        value
        4
      4. group Id
        OG003
        value
        8
      5. group Id
        OG004
        value
        4
      6. group Id
        OG005
        value
        2
      units
      Participants
    title
    AUC(0-Clast) Hx-DR5-05 Cycle 2 Day 1
  6. categories
    1. measurements
      1. group Id
        OG000
        spread
        168.7
        value
        20.12
      2. group Id
        OG001
        spread
        539.4
        value
        16.95
      3. group Id
        OG002
        spread
        405.4
        value
        43.56
      4. group Id
        OG003
        spread
        76.4
        value
        158.98
      5. group Id
        OG004
        spread
        22162.5
        value
        52.16
      6. comment
        Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.
        group Id
        OG005
        spread
        NA
        value
        2248.1
    denoms
    1. counts
      1. group Id
        OG000
        value
        7
      2. group Id
        OG001
        value
        4
      3. group Id
        OG002
        value
        2
      4. group Id
        OG003
        value
        6
      5. group Id
        OG004
        value
        3
      6. group Id
        OG005
        value
        1
      units
      Participants
    title
    AUC(0-Clast) Hx-DR5-05 Cycle 3 Day 1
denoms
  1. counts
    1. group Id
      OG000
      value
      9
    2. group Id
      OG001
      value
      7
    3. group Id
      OG002
      value
      4
    4. group Id
      OG003
      value
      11
    5. group Id
      OG004
      value
      7
    6. group Id
      OG005
      value
      6
    units
    Participants
description
The AUC(0-Clast) of Hx-DR5-01 and Hx-DR5-05 are reported.
dispersion Type
Geometric Coefficient of Variation
groups
  1. description
    Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
    id
    OG000
    title
    Biweekly Regimen (GEN1029 0.1 mg/kg)
  2. description
    Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
    id
    OG001
    title
    Biweekly Regimen (GEN1029 0.2 mg/kg)
  3. description
    Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
    id
    OG002
    title
    Biweekly Regimen (GEN1029 0.3 mg/kg)
  4. description
    Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
    id
    OG003
    title
    Biweekly Regimen (GEN1029 1.0 mg/kg)
  5. description
    Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
    id
    OG004
    title
    Biweekly Regimen (GEN1029 2.0 mg/kg)
  6. description
    Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
    id
    OG005
    title
    Biweekly Regimen (GEN1029 3.0 mg/kg)
param Type
GEOMETRIC_MEAN
population Description
PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
reporting Status
POSTED
time Frame
Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
title
Area Under Plasma Concentration-time Curve From Time Zero to the Time of Last Nonzero Concentration (AUC[0-Clast]) of Hx-DR5-01 and Hx-DR5-05
type
SECONDARY
unit Of Measure
µg*h/mL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice